The $100m venture financing of JenaValve Technology was the medical devices industry’s top cross border venture financing deal as total deals worth $439.9m were announced globally in August 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 47.03% over the previous month of $830.41m and a drop of 53.2% when compared with the last 12-month average, which stood at $939.49m.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $312m. At the country level, the US topped the list in terms of deal value at $284m.
In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of cross border venture financing deals activity in August 2022 was the US with seven deals, followed by the UK with two and China with two.
In 2022, as of August, medical devices cross border venture financing deals worth $6.91bn were announced globally, marking an increase of 32.5% year on year.
medical devices industry cross border venture financing deals in August 2022: Top deals
The top five medical devices industry cross border venture financing deals accounted for 65.8% of the overall value during August 2022.
The combined value of the top five medical devices cross border venture financing deals stood at $289.57m, against the overall value of $439.9m recorded for the month.
The top five medical devices industry cross border venture financing deals of August 2022 tracked by GlobalData were:
1) Andera Partners, Bain Capital Life Sciences, Cormorant Asset Management, Gimv, Innovatus Capital Partners, Peijia Medical, Pictet Alternative Advisors, Qatar Investment Authority, RMM Consulting Group, Valiance Advisors and Venture Incubator’s $100m venture financing deal with JenaValve Technology
2) The $52.57m venture financing of CureApp by The Carlyle Group
3) Novo Holdings’s $50m venture financing deal with MedGenome
4) The $45m venture financing of Theranica by aMoon Partners, Corundum Open Innovation, Lightspeed Management Company, Lionbird, New Rhein Healthcare Investors and Takoa Invest
5) AMED Ventures GP, Cormorant Asset Management, PA MedTech VC Fund, Shifamed Angels and The Capital Partnership – UK’s $42m venture financing deal with Atia Vision
Related Companies
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
